Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jan 16;303(5656):359-63.
doi: 10.1126/science.1092436. Epub 2003 Dec 11.

Defining the epithelial stem cell niche in skin

Tudorita Tumbar  1 , Geraldine Guasch, Valentina Greco, Cedric Blanpain, William E Lowry, Michael Rendl, Elaine Fuchs
Affiliations

Defining the epithelial stem cell niche in skin

Tudorita Tumbar et al. Science. .

Abstract

Many adult regenerative cells divide infrequently but have high proliferative capacity. We developed a strategy to fluorescently label slow-cycling cells in a cell type-specific fashion. We used this method to purify the label-retaining cells (LRCs) that mark the skin stem cell (SC) niche. We found that these cells rarely divide within their niche but change properties abruptly when stimulated to exit. We determined their transcriptional profile, which, when compared to progeny and other SCs, defines the niche. Many of the >100 messenger RNAs preferentially expressed in the niche encode surface receptors and secreted proteins, enabling LRCs to signal and respond to their environment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
System for marking slow-cycling SCs in vivo and monitoring their fate. (A) Strategy. (B to D) Skin sections of mice before and after 4-week chase. Shown are epifluorescence of H2B-GFP (green) and 4′,6′-diamidino-2-phenylindole (DAPI) (blue), and indirect immunofluorescence with antibodies (Abs) indicated (Texas Red). The hair cycle stage is indicated on each set of “after chase” frames (see also fig. S1, B to D, and fig. S2). Arrows (B) denote Ki67+ sebaceous gland cells in telogen. Arrowheads [(B) and (C)] denote transition zone between bulge and newly generated follicle downgrowth. Late anagen (Ki67 in red): GFP-bright cells are retained in the bulge; their progeny rapidly divide, diluting H2B-GFP. (D) Early anagen II bulb overexposed for GFP and double-labeled (small arrowheads) with Abs against each differentiation cell type. (E) Mice “after chase” were scratch-wounded and analyzed by immunofluorescence. Arrows denote likely directions of movements of GFP-positive LRCs and progeny. Abbreviations: Bu, bulge; DP, dermal papilla; Mx, matrix; hg, hair germ; Ep, epidermis; asterisk, hair shaft (autofluorescent); hf, hair follicle; Cx, cortex; ORS/IRS, outer/inner root sheaths; BM, basement membrane; In, infundibulum; W, wound. Scale bars, 50 μm.
Fig. 2
Fig. 2
Isolation and preliminary characterization of bulge LRCs and progeny. Animals were Tet-fed for 4 weeks beginning at t = 4 weeks. (A) FACS analyses of single-cell suspensions of skins. GFP fluorescence (FL) is in arbitrary units. (B) Two-color FACS analyses for GFP and five surface markers. α6/CD34 data illustrate that GFPhigh LRCs represent only ∼30% of α6/CD34/K5-H2B-GFP–positive cells. White, without primary Abs; red, with Abs. Percentages of total cells scoring positive are indicated. (C) GFPhigh FACS population analyzed by immunofluorescence to illustrate homogeneity. Figure S4B provides quantification of all three fractions screened for six markers. (D) Propidium iodide (PI)–FACS cell cycle profiles by DNA content: G0/G1 (n = 1), G2/M (n = 2), and S (n = 1 or 2). Percentage of total cells in G2/M is indicated.
Fig. 3
Fig. 3
Transcriptional profiling of bulge LRCs relative to other SCs. Duplicate mRNAs of bulge LRCs and their two progeny populations were amplified and hybridized to Affymetrix oligonucleotide chips. Files were analyzed by Microarray Suite (MAS5.0) Affymetrix software followed by public database searches, functional annotation, and comparison with similar databases from embryonic (ESC), neural (NSC), and hematopoietic (HSC) SCs (15, 16). (A) Bar graphs: Percentage of mRNAs called present in skin LRCs (4839 total; left) and of mRNAs increased in LRCs versus BL/ORS (154 total; right) and also called present in three other SCs (black), two other SCs (red), one other SC (yellow), and no other SCs (white). (B) GFP epifluorescence and immunofluorescence of skin sections from 8-week-old mice after 4-week chase. Abs are against known SC markers found up-regulated in bulge LRCs. Abbreviations are as in Fig. 1 legend; scale bars, 50 μm. Lower magnification for tenascin-C illustrates marker-specificity. (C) Semiquantitative RT-PCR. Probes are for SC markers, up-regulated in skin LRCs. Mouse ESC mRNAs are shown for comparison. PCR was run for 29, 32, and 35 cycles.
Fig. 4
Fig. 4
Implementation of array analyses to examine characteristics and dynamics of the skin SC niche. GFP (green) and immunofluorescence (red) of skin sections from 8-week-old mice (4-week chase). Examples shown: (A) An mRNA up-regulated >2× in LRCs relative to epidermis/ORS. (B) Activated (nuclear phospho-Smad2; arrowheads) or up-regulated (LTBP-1) LRC factors involved in TGFβ signaling. Quantification is at right (graph). (C) Tissue polarity proteins expressed in the SC niche. EphA4, EphB4, and EfnB1 (right of EphB4); boxed bulge in frame is also shown with GFP colabeling. (D) Dynamics of the niche during cycles of SC activation (telogen/anagen transition). Abbreviations are as in Fig. 1 legend; APMu, arrector pili muscle; asterisk denotes hair shaft autofluorescence. Scale bars, 50 μm.
Fig. 5
Fig. 5
Comparison of cellular localization of bulge LRC mRNAs increased relative to BL/ORS and mRNA present in LRCs. Left, increased in LRCs relative to BL/ORS (154 total); right, present in skin LRCs (three pools of 150 mRNAs each of the 4839 present were analyzed). Black, expressed sequence tags; red, intracellular/cytosolic; blue, nuclear; gray, integral to membrane; white, secreted.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fuchs E, Raghavan S. Nature Rev. Genet. 2002;3(199) - PubMed
    1. Potten CS, Morris RJ. J. Cell Sci. Suppl. 1988;10(45) - PubMed
    1. Mackenzie IC. J. Invest. Dermatol. 1997;109(377) - PubMed
    1. Cotsarelis G, Sun TT, Lavker RM. Cell. 1990;61(1329) - PubMed
    1. Morris RJ, Potten CS. J. Invest. Dermatol. 1999;112(470) - PubMed

Publication types

MeSH terms

-